vs
美国合众银行（CBNK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是美国合众银行的1.2倍（$75.5M vs $62.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.6%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 23.7%）
美国合众银行是一家总部位于明尼苏达州明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年是美国第五大银行，同时也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，其核心运营主体为美国银行国民协会，以合众银行名义开展业务，提供银行、投资、抵押贷款等多元金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CBNK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$62.7M
营收增速更快
PBYI
高出16.2%
11.6%
两年增速更快
PBYI
近两年复合增速
23.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.7M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 31.4% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 11.6% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.92 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBNKPBYI
| Q4 25 | $62.7M | $75.5M | ||
| Q3 25 | $63.1M | $54.5M | ||
| Q2 25 | $60.8M | $52.4M | ||
| Q1 25 | $58.6M | $46.0M | ||
| Q4 24 | $56.2M | $59.1M | ||
| Q3 24 | $45.0M | $80.5M | ||
| Q2 24 | $43.9M | $47.1M | ||
| Q1 24 | $41.0M | $43.8M |
净利润CBNKPBYI
| Q4 25 | — | — | ||
| Q3 25 | $15.1M | $8.8M | ||
| Q2 25 | $13.1M | $5.9M | ||
| Q1 25 | $13.9M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.7M | $20.3M | ||
| Q2 24 | $8.2M | $-4.5M | ||
| Q1 24 | $6.6M | $-4.8M |
毛利率CBNKPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CBNKPBYI
| Q4 25 | 31.4% | 22.7% | ||
| Q3 25 | -1.5% | 17.6% | ||
| Q2 25 | -1.5% | 12.7% | ||
| Q1 25 | -1.5% | 8.7% | ||
| Q4 24 | -2.2% | 22.6% | ||
| Q3 24 | -2.2% | 27.4% | ||
| Q2 24 | -1.8% | -4.6% | ||
| Q1 24 | -2.3% | -5.3% |
净利率CBNKPBYI
| Q4 25 | — | — | ||
| Q3 25 | 23.9% | 16.2% | ||
| Q2 25 | 21.6% | 11.2% | ||
| Q1 25 | 23.8% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.3% | 25.2% | ||
| Q2 24 | 18.7% | -9.6% | ||
| Q1 24 | 16.0% | -11.0% |
每股收益（稀释后）CBNKPBYI
| Q4 25 | $0.92 | $0.26 | ||
| Q3 25 | $0.89 | $0.17 | ||
| Q2 25 | $0.78 | $0.12 | ||
| Q1 25 | $0.82 | $0.06 | ||
| Q4 24 | $0.44 | $0.40 | ||
| Q3 24 | $0.62 | $0.41 | ||
| Q2 24 | $0.59 | $-0.09 | ||
| Q1 24 | $0.47 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $401.8M | $130.3M |
| 总资产 | $3.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CBNKPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务CBNKPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CBNKPBYI
| Q4 25 | $401.8M | $130.3M | ||
| Q3 25 | $394.8M | $115.3M | ||
| Q2 25 | $380.0M | $104.7M | ||
| Q1 25 | $369.6M | $97.1M | ||
| Q4 24 | $355.1M | $92.1M | ||
| Q3 24 | $280.1M | $71.1M | ||
| Q2 24 | $267.9M | $48.5M | ||
| Q1 24 | $259.5M | $51.0M |
总资产CBNKPBYI
| Q4 25 | $3.6B | $216.3M | ||
| Q3 25 | $3.4B | $202.9M | ||
| Q2 25 | $3.4B | $194.9M | ||
| Q1 25 | $3.3B | $196.2M | ||
| Q4 24 | $3.2B | $213.3M | ||
| Q3 24 | $2.6B | $220.7M | ||
| Q2 24 | $2.4B | $205.0M | ||
| Q1 24 | $2.3B | $214.1M |
负债/权益比CBNKPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $69.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CBNKPBYI
| Q4 25 | $69.7M | $14.4M | ||
| Q3 25 | $32.9M | $9.7M | ||
| Q2 25 | $-4.2M | $14.1M | ||
| Q1 25 | $22.6M | $3.6M | ||
| Q4 24 | $34.9M | $15.6M | ||
| Q3 24 | $-464.0K | $11.0M | ||
| Q2 24 | $12.9M | $1.0M | ||
| Q1 24 | $-3.4M | $11.2M |
自由现金流CBNKPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率CBNKPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度CBNKPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率CBNKPBYI
| Q4 25 | — | — | ||
| Q3 25 | 2.18× | 1.10× | ||
| Q2 25 | -0.32× | 2.41× | ||
| Q1 25 | 1.62× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.05× | 0.54× | ||
| Q2 24 | 1.57× | — | ||
| Q1 24 | -0.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
